Email updates

Keep up to date with the latest news and content from Cardiovascular Ultrasound and BioMed Central.

Open Access Research

Reduced fractional shortening of right ventricular outflow tract is associated with adverse outcomes in patients with left ventricular dysfunction

Masashi Yamaguchi1, Toshihiro Tsuruda1*, Yuki Watanabe2, Hisamitsu Onitsuka1, Kuniko Furukawa3, Takeshi Ideguchi1, Junji Kawagoe1, Tetsunori Ishikawa1, Johji Kato4, Makoto Takenaga2 and Kazuo Kitamura1

Author Affiliations

1 Department of Internal Medicine, Circulatory and Body Fluid Regulation, Faculty of Medicine, University of Miyazaki, 5200 Kihara Kiyotake, Miyazaki 889-1692, Japan

2 Internal Medicine, Fujimoto Central Hospital, 3584-1 Midarebashi Kitakawauchi, Miyazaki 880-0941, Japan

3 Clinical laboratory, Miyazaki University Hospital, 5200 Kihara Kiyotake, Miyazaki 889-1692, Japan

4 Frontier Science Research Center, University of Miyazaki, 5200 Kihara Kiyotake, Miyazaki 889-1692, Japan

For all author emails, please log on.

Cardiovascular Ultrasound 2013, 11:19  doi:10.1186/1476-7120-11-19

Published: 3 June 2013

Abstract

Background

Recent studies suggest the significance of right ventricular (RV) function in the outcome in patients with left ventricular dysfunction (LVSD); however, global assessment of RV remains to be determined by echocardiogram because of its complex geometry. This study aimed to validate RV outflow tract fractional shortening (RVOT-FS) in the evaluation of RV function and its prognostic value in patients with LVSD.

Methods

This study included eighty-one patients (62 ± 17 years, mean ± SD, male 79%) with reduced LV ejection fraction (LVEF) (≤40%). Two-dimensional echocardiogram of the parasternal short axis view was obtained at the level of the aortic root, and RVOT-FS was calculated as the ratio of end-diastole minus end-systole dimension to end-diastole dimension.

Results

RVOT-FS ranged from 0.04 to 0.8 (0.3 ± 0.2, mean ± SD), and correlated with LVEF (r = 0.33, p = 0.0028), RV fractional area change (r = 0.37, p = 0.0008) and brain natriuretic peptide level (r = -0.38, p = 0.0005). In Cox multivariate regression analysis, RVOT-FS [hazard ratio (HR) 0.028, 95% confidence interval (CI): 0.002-0.397]; p = 0.008] and New York Heart Association functional class III-IV [HR 2.233, 95% CI: 1.048-4.761]; p = 0.037] were independent factors to predict the events. During a median follow-up period of 319 days (1 to 1862 days), patients with RVOT-FS ≥ 0.2 showed a higher event-free rate than those < 0.2 by Kaplan-Meier analysis (log-rank test, p = 0.0016).

Conclusions

Our data suggest that RVOT-FS is a simple parameter reflecting the severity of both ventricular function in patients with LVSD. In addition, RVOT-FS might be useful to predict adverse outcomes in such a patient population.

Keywords:
Heart failure; Right ventricle; Brain natriuretic peptide